LT3001 DEMONSTRATES FUNCTIONAL IMPROVEMENTS IN PATIENTS WITH DISABLING ACUTE ISCHEMIC STROKE
Breakthrough Phase 2 Trial Results Show Promise for Patients Ineligible for Standard Reperfusion Therapies
Data Presented at International Stroke Conference
Data Show That LT3001 Delivers Meaningful Functional Improvements in Pat… อ่านเพิ่ม

















